Canadian Centre on Substance Use and Addiction

CCENDU Bulletin: Update on Xylazine in Canada and the United States

This Bulletin updates recent data on xylazine’s presence in the unregulated drug supply from a CCENDU alert in July 2022. It also assesses concerns among community partners and highlights public health-based solutions. CCENDU partnered with the National Drug Early Warning System (NDEWS) in the United States and the Public Health Agency of Canada to create the update.

We use cookies to ensure that we give you the best experience possible on our website. 

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.